The global telemedicine market size was estimated to be $144.38 billion in 2020.  As a result of the COVID-19 impact, the telehealth market grew an estimated 135.2% in 2020 compared to the average annual growth rate during the 2017-2019 period.  The market is projected to grow to an estimated $636.38 billion in 2028 at a CAGR of 32.1% over the 7-year period. In the US alone, IBISWorld estimates the telehealth services market to be $3.5 billion in 2021 and grow by 9.6% for the full year 2021. However, as of late summer 2021, virtual visits have stabilized, but still at levels much higher than before the pandemic.  Although telehealth visits continue to grow, the growth has slowed considerably … [Read more...]

The urgent care industry has been growing steadily over the last decade. But the last 18 months have shown a significant increase in patient visits to urgent care facilities. In fact, new patients nearly doubled compared to the previous year based on data gathered by Experity[1]. The COVID-19 pandemic has driven a large portion of the demand due to testing requirements and overcrowded ERs. But the surge of attention doesn’t seem likely to fade away after the pandemic either. Over the last 18 months, the urgent care industry has been able to showcase its many advantages and, in some cases, offer an alternative solution to emergency departments. Urgent Care vs ER Urgent care … [Read more...]

The DOJ has cracked down on recent fraud facilitated by the COVID-19 pandemic and telehealth services. 138 medical professionals were recently charged for alleged healthcare fraud, with the bulk of the scams being committed by telemedicine executives. The charges target over $1 billion in fraud committed by telehealth services. This is accompanied by $133 million in schemes related to substance abuse treatment facilities and $160 million in illegal opioid distribution and other healthcare fraud. Court documents state that telehealth executives allegedly compensated medical professionals to order unnecessary medical equipment, diagnostic testing, and pain medications with minimal to no … [Read more...]

The HVG staff reviews the DOJ enforcement actions on the daily, and lately we’re seeing a frequent fraud in the form of overprescribing and kickback schemes in the following areas: DME prescriptionsToxicology labs and urinating testingGenetic testingPain creamsPain medicationsSubstance abuse clinics The latest case released by the DOJ involves a Virginia Dr. who was prescribing expensive compounded pain and scar creams and referred the patients to a compounding pharmacist in return for “a percentage of the profits….” read more here... … [Read more...]

The use of artificial intelligence (AI) is rapidly evolving and the demand for data is rapidly growing.  Many industries are finding ways to deploy AI technology to improve efficiencies, increase sales, lower costs and automate processes. In the healthcare space, hospitals, insurers, medical device companies, and pharmaceutical companies are generating, collecting, acquiring and utilizing data for AI and value-based arrangements. Generally speaking, the more data the better.  As such, data is valuable.  But the question is, just how valuable?  This question is now being raised and will continue to grow in popularity. Data in the healthcare space is used to improve the … [Read more...]

The management services organization (MSO) business model seems to be really popular of late. This is especially so with telehealth businesses since most are structured as an MSO and friendly PC model.  HVG is regularly asked to issue an FMV opinion on the management fee related to a management services agreement (MSA). Here is a short explanation of how appraisers should estimate the FMV of management services. As an appraiser, we encounter certain unique challenges when it comes to opining to an FMV management fee. First, in certain states with restrictions on fee-splitting and/or where the corporate practice of medicine (CPOM) is in force the management fee cannot be contracted … [Read more...]

According to the National Association of Specialty Pharmacy, a specialty pharmacy is a state-licensed pharmacy that solely or largely provides medications and services for people with chronic or complex health conditions. Specialty medications are more complex and expensive than most prescription medications and may be taken orally but are often injected or infused. Specialty drugs are prescribed for the treatment of various chronic diseases and conditions, such as cancer, hepatitis C, rheumatoid arthritis, HIV/AIDS, multiple sclerosis, cystic fibrosis, organ transplantation, hemophilia, allergies, heart failure, and stroke. Specialty drugs account for approximately 50% of the … [Read more...]

The impact of COVID-19 has been unprecedented and staggering, with behavioral health services witnessing a positive demand shock across the U.S. during the pandemic period. Demand for behavioral health services jumped significantly in 2020, with a sharp rise in suicide attempts and drug overdoses. According to a report by McKinsey & Company, the US saw a 50% increase in the prevalence of behavioral health conditions as a result of the COVID-19 pandemic. In 2020, mental health providers faced decreased revenues and increased costs, all as demand spiked. Clinicians who had in-person daily visits witnessed a devastating income loss owing to the stay-at-home restrictions imposed. However, … [Read more...]